The Chinese government is the primary life science investor in China. To support education and research, both central and local governments dedicate funds to universities and institutes. The Chinese Academy of Sciences (CAS) and the National Science Foundation of China (NSFC), both funded directly by the central government, invest in research and spin-off companies.
One of Read more »
In recent years, both the international and Chinese media have been inundated with Chinese claims of progress in stem cell research. The media is not alone in its notice of China’s stem cell work. Chinese scientists are publishing increasing numbers of stem cell manuscripts in international peer reviewed journals, and in November, 2007, Shanghai played Read more »
Because of the worldwide economic distress, business activity is shrinking almost universally, though some individual areas are demonstrating relative strength – and we think the life science industry in China is one of those areas. In this series of articles, ChinaBio® presents proprietary data developed by its own team of researchers that explains why we Read more »
The biotechnology space in China, once a disjointed constellation of institutes, scientists, companies and investors, has grown into a bone fide industrial sector, complete with the acceleration in growth (and exposure of areas needing improvement) that accompanies such a metamorphosis. Not surprisingly, the Chinese biotech industry is also becoming increasingly enmeshed in the international biopharmaceutical Read more »
Newsletter